CLDN1 and glioblastoma: Immunohistochemical analysis revealed that PARVB expression was positively correlated with the mesenchymal markers N-cadherin and Vimentin, and negatively correlated with the epithelial markers E-cadherin and Claudin-1 in GBM tissues (Figure 8A).